CELLINK completes the acquisition of MatTek Corporation
As announced on March 10, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the American company MatTek Corporation (“MatTek”), focusing on advanced in-vitro technology for clinical and pre-clinical studies offering in-vitro human tissue model innovation, cell isolation and cell culture. CELLINK has on this day completed the acquisition of all MatTek-shares.The purchase price for all shares amounted to approximately MUSD 72, including an adjustment of approximately MUSD 4 for net cash and deviation from normalized working capital, of which approximately MUSD 13.6 was